A clear CJC-1295 (DAC) research vial on a coloured plaster ledge, with botanicals beside it

About this compound

CJC-1295 with DAC is the same 29-residue GRF analogue carrying an additional lysine at position 30 bearing a maleimidoproprionic acid Drug Affinity Complex.

Studied in

  • GH/IGF-1 axis
  • Half-life comparison
  • Endocrine signalling

Compound identity

CompoundCJC-1295 (DAC)
CAS number446262-90-4
Molecular formulaC165H269N47O46
Molecular weight3,647.2 Da

Specifications

  • Purity method: HPLC
  • Appearance: Lyophilized powder
  • Solubility: Reconstitute per protocol; see Supplies for diluents.
  • We don't publish a purity percentage here — that figure is only meaningful tied to the lot you actually receive, so it lives on the lot certificate.

Endocrine

LONGWAVE

CJC-1295 (DAC)

Long-acting GHRH analog with drug-affinity complex.

What the research targets

Studied for its extended half-life relative to the no-DAC form in GH-axis research models.

Supply formats

Single units ship from stock. Cases are back-ordered against the same single-unit price.

Stick is newly released — available alongside the vial on every compound.

Single unit

Sample quantity — one unit.

  • 5 mgVial

    PS-9887787-5-MG

    On verified account
  • Skinni Stick™ 5 mgSkinni Stick™New

    Single-compound Skinni Stick™. Supplied to verified accounts only.

    PS-9887787-PEN-5-MG

    On verified account

Case — back-order

Ten of one size, at 10× volume pricing.

  • Case · 10 × 5 mg

    Back-order — 15% off the single-unit price.

    PS-9887787-C10-5-MG

    On verified account
  • Case · 10 × Skinni Stick™ 5 mgNew

    Back-order — 15% off the single-unit price.

    PS-9887787-C10-PEN-5-MG

    On verified account

One-time verification of professional or institutional affiliation. No payment is taken on this site.

Research use only

This compound is supplied exclusively for laboratory research by qualified professionals and institutions. It is not a drug, dietary supplement, or cosmetic, and is not for human or veterinary use. We publish no dosing, administration, or human-use guidance of any kind, and nothing here should be read as a claim about an effect in people.

From the research library

Cited summaries of the published work behind CJC-1295 (DAC) — what was studied, in which model, and what was measured.

All articles

More in Endocrine